Skip to main content

Table 1 Sociodemographic and clinical characteristics of the sample (N = 281)

From: Validation study of the Functional Assessment of Cancer Therapy-Cognitive Function-Version 3 for the Portuguese population

Characteristic

N (%)

Age (Years) [Mean (SD), range]

45.97 (9.00), 18–65

Gender

 

 Female

268 (95.4%)

 Male

13 (4.6%)

Marital status

 

 Single

55 (19.6%)

 Married

148 (52.7%)

 Cohabitation

34 (12.1%)

 Divorced or separated

43 (15.3%)

 Widowed

1 (0.4%)

Children (Yes)

211 (75.1%)

Education

 

 Less than 4 years of education

1 (0.4%)

 1st Cycle (4th year complete)

5 (1.8%)

 2nd Cycle (6th year complete)

4 (1.4%)

 3rd Cycle (9th year complete)

13 (4.6%)

 Secondary Education (12th year complete)

87 (30.9%)

 Higher Education—Bachelor’s degree

117 (41.7%)

 Higher Education—Master’s degree

48 (17.1%)

 Higher Education—Doctoral degree

6 (2.1%)

Education (Years) [Mean (SD), range]

15.56 (3.87), 4–29

Occupation

 

 Working (part- and full-time)

185 (66.1%)

 Medical leave

56 (20.1%)

 Unemployed

20 (7.2%)

 Student

6 (2.2%)

 Retired

14 (5.0%)

Monthly income (euros)

 

 < 500€

28 (10%)

 500€–999€

104 (37.0%)

 1000€–1499€

77 (27.4%)

 1500€–1999€

45 (16.0%)

 > 2000€

27 (9.6%)

Cancer type

 

 Bladder

1 (0.4%)

 Lung

8 (2.8%)

 Uterus

3 (1.1%)

 Leukemia

5 (1.7%)

 Hodgkin Lymphoma

17 (6.0%)

 Non-Hodgkin Lymphoma

10 (3.6%)

 Melanoma

3 (1.1%)

 Multiple Myeloma

3 (1.1%)

 Cervical

6 (2.1%)

 Colorectal

17 (6.0%)

 Stomach

2 (0.7%)

 Breast

176 (62.7%)

 Ovarian

11 (3.9%)

 Skin non-melanoma

3 (1.1%)

 Thyroid

6 (2.3%)

 Other (e.g., nasopharynx, liver, sarcoma)

10 (3.9%)

Year of cancer diagnosis

 

 ≤ 2000

3 (1.1%)

 2001–2005

3 (1.1%)

 2006–2010

24 (9.5%)

 2011–2015

80 (31.9%)

 2016–2021

171 (68.3%)

Previous treatments

 

 None

7 (2.5%)

 Surgery

233 (82.9%)

 Radiation therapy

168 (59.8%)

 Chemotherapy

227 (80.8%)

 Hormone therapy

138 (49.1%)

 Immunotherapy

39 (13.9%)

 Other

41 (14.6%)

Ongoing treatments

 

 None

161 (57.3%)

 Surgery

0 (0.0%)

 Radiation therapy

7 (2.5%)

 Chemotherapy

14 (5.0%)

 Hormone therapy

84 (29.9%)

 Immunotherapy

13 (4.6%)

 Other

19 (6.8%)

Use of mental health services (Yes)

72 (25.6%)

  1. SD standard deviations